Single-Photon Emission Computed Tomography Market: Size, Growth Analysis & Forecast 2025-2034

According to Statifacts, the global Single-Photon Emission Computed Tomography market trends are estimated to be worth USD 2,840 million in 2024 and are anticipated to reach a value of USD 5,590 million by 2034. Sales are projected to rise at a CAGR of 7% over the forecast period between 2024 and 2034.
𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐃𝐚𝐭𝐚𝐛𝐨𝐨𝐤 (Price USD 1550) https://www.statifacts.com/order-report/6880

The single-photon emission computed tomography (SPECT) is a crucial segment of the healthcare industry. A SPECT is type of 3D imaging technique that uses nuclear medicine (short-life radioisotopes) and a special gamma camera to obtain 3D images of the functional and metabolic processes inside the human body. It is a non-invasive diagnostic imaging technique with various applications such as detection of cancers, neurological disorders among others.

The increasing use of artificial intelligence (AI) in SPECT with the use of deep learning algorithms and machine learning tools for enhancing image quality, attenuated correction, improved diagnostic accuracy, disease prediction and reduced interpretation time is attributing to the growth of this technique worldwide. Moreover, the rising investments in advanced diagnostic centres, strategic partnerships and collaborations between major market players, technological advancements, support from government bodies for developing innovative SPECT scanners is promoting the overall growth of the market.

The rising prevalence of cancer, neurological diseases and cardiovascular diseases and the demand for advanced diagnostic imaging techniques is expected to build growth opportunities for the market players in the impending years.

𝐔𝐧𝐥𝐨𝐜𝐤 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐛𝐲 𝐞𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤@ https://www.statifacts.com/download-product/6880

Future Trends

Several emerging trends are expected to shape the future of the SPECT market:

1. Integration of Artificial Intelligence (AI): AI-powered analytics and automated image processing are enhancing diagnostic accuracy and efficiency.

2. Development of Novel Radiopharmaceuticals: Advances in radiotracers are improving disease detection and monitoring.

3. Miniaturization of Imaging Systems: Portable and compact SPECT devices are being developed for point-of-care applications.

4. Expansion into Outpatient and Homecare Settings: The growing trend towards outpatient care is expected to drive demand for smaller, user-friendly imaging systems.

Market Concentration & Characteristics

The industry is accelerating at a high growth rate and is witnessing significant innovation, major companies such as GE Healthcare, Siemens Healthineers, and Koninklijke Philips N.V. have established significant market shares due to their extensive product portfolios, strong research and development capabilities, and wide distribution networks. These industry leaders continue to invest in technological innovations to enhance imaging accuracy and efficiency, thereby maintaining their competitive edge. The market is marked by high barriers to entry due to the significant capital investment required for research and development, manufacturing, and regulatory compliance. In addition, the SPECT market is characterized by its reliance on cutting-edge technology and the need for continuous advancements to meet evolving clinical demands. This surge in diverse application is a key factor driving the industry's rapid growth.

The growing R&D activities in bringing novel products is driving industry. The development of cutting-edge technologies in SPECT and CT modalities is poised to fuel market growth. A recent milestone in this regard was the launch of the Symbia Pro.specta, a SPECT/CT system introduced by Siemens Healthineers in June 2022. This innovative system has earned both CE mark and FDA clearance, and its advanced features are set to revolutionize medical imaging.

Single-photon emission computed tomography (SPECT) industry have seen significant innovations driven at enhancing automatic SPECT motion correction, enhancing image clarity. Furthermore, market is characterized by a high degree of innovation, driven by continuous advancements in imaging technology and radiopharmaceutical development. Leading companies in the market are heavily investing in research and development to enhance image quality, improve diagnostic accuracy, and expand the clinical application of SPECT imaging.

Companies that manufacture single-photon emission computed tomography (SPECT) systems are undertaking merger and acquisition activities. This strategic approach seeks to improve technological capabilities, expand industry reach, and maintain competitiveness. For instance, in May 2022, Mediso Ltd, a prominent player in the SPECT market, made a significant announcement: the company has plans to acquire Bartec Technologies Ltd. Based in the UK, Bartec is a specialized company that focuses on supplying and installing molecular imaging equipment and accessories.

Regulatory bodies like the US Food and Drug Administration (FDA), Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) play a crucial role in shaping the development and application of single-photon emission computed tomography (SPECT). Recently, in November 2020, NanoMab Technology Limited has received Clinical Trial Authorization (CTA) acceptance from the Medicines and Healthcare products Regulatory Agency (MHRA) to conduct a Phase II clinical study for its NM-01 product. This study aims to evaluate the expression of programmed death-ligand 1 (PD-L1) using 99mTc-NM-01 as a SPECT/CT radiotracer and compare it with PD-L1 expression results obtained from routine immunohistochemical (IHC) testing in biopsy diagnostic specimens.

The industry is characterized by low level of substitute by imaging technologies, such as PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging), which offer different advantages depending on clinical needs. As a result, companies in the SPECT market are focusing on differentiating their products through technological advancements and the development of hybrid imaging systems that combine SPECT with other modalities such as CT to enhance diagnostic accuracy.

Regional expansion is a key strategy for growth, with companies seeking to penetrate emerging markets in Asia Pacific and Latin America where demand for advanced imaging technologies is rising due to improving healthcare infrastructure and increasing awareness of early disease detection.

Recent Developments

• In May 2024, the Cancer Centre London has introduced a new state-of-the-art SPECT/CT imaging system from ICON and Nuttified health, marking a significant advancement in diagnostic capabilities at the facility. This innovative system combines SPECT (Single Photon Emission Computed Tomography) with CT (Computed Tomography) to provide highly detailed and accurate imaging for cancer diagnosis and treatment planning.

• In January 2024, GE Healthcare announced a partnership to acquire MIM Software, a global leader in medical imaging analysis and artificial intelligence (AI) solutions. MIM Software specializes in providing advanced solutions for radiation oncology, molecular radiotherapy, diagnostic imaging, and urology. Their offerings are designed for a wide range of clients, including imaging centers, hospitals, specialty clinics, and research organizations around the world.

• In June 2022, Siemens Healthineers launched the Symbia Pro.Specta, a SPECT/CT system that has been awarded both CE mark and FDA clearance. This system combines advanced SPECT and CT imaging technologies, featuring a low-dose CT that can capture up to 64 slices, providing exceptional imaging detail.

Single-Photon Emission Computed Tomography Market Top Key Companies:
• Bruker Corp.
• DDD-Diagnostic AS
• Digmed Corp.
• General Electric Co.
• Mediso Ltd.
• MiE GmbH
• MILabs BV
• Siemens Healthineers AG
• Spectrum Dynamics Medical Inc.
• GE Healthcare
• CardiArc
• Beijing Hamamatsu Photon Techniques INC.
• SHENZHEN BASDA MEDICAL APPARATUS CO. LTD.
• PNPMed
• NuCare Inc.

Global Single-Photon Emission Computed Tomography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. For this study, Statifacts has segmented the global Single-Photon Emission Computed Tomography Market
By Product

• Single Imaging Gamma Cameras
• SPECT/CT

By Application

• Cardiology
• Oncology
• Neurology
• Others

By End User
• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers

By Regional

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐃𝐚𝐭𝐚𝐛𝐨𝐨𝐤@ https://www.statifacts.com/order-report/6880

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

Anti-microbial/Anti-fungal Tests Market - https://www.statifacts.com/outlook/anti-microbial-anti-fungal-tests-market
Single-Photon Emission Computed Tomography Market;
https://www.statifacts.com/outlook/single-photon-emission-computed-tomography-market
Arthroscopy Devices Market; https://www.statifacts.com/outlook/arthroscopy-devices-market
Novel Drug Delivery Systems In Cancer Therapy Market -https://www.statifacts.com/outlook/novel-drug-delivery-systems-in-cancer-therapy-market

Medical Equipment Reimbursement Market ; https://www.statifacts.com/outlook/medical-equipment-reimbursement-market

Photoacoustic Microscopy Market - https://www.statifacts.com/outlook/photoacoustic-microscopy-market

Statifacts offers subscription services for data and analytics insights. This page provides options to explore and purchase a subscription tailored to your needs, granting access to valuable statistical resources and tools. Access here - https://www.statifacts.com/get-a-subscription

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐒

• Ballindamm 22, 20095 Hamburg, Germany
• Email: sales@statifacts.com
• Web: https://www.statifacts.com/
• Europe : +44 7383 092 044

𝐀𝐛𝐨𝐮𝐭 𝐔𝐒

Statifacts is a leading provider of comprehensive market research and analytics services, offering over 1,000,000 market and custoer data sets across various industries. Their platform enables businesses to make informed strategic decisions by providing full access to statistics, downloadable in formats such as XLS, PDF, and PNG.

Visit Our Sitemap ; https://www.statifacts.com/outlook/sitemap.xml

This release was published on openPR.